2020 PEA Program - Medhavi Gupta MD, Breast Cancer Series Antibody-Drug Conjugate Treatment Options

Article and Video CATEGORIES

Cancer Journey

ABOUT

Dr. Gupta is currently a Hematology-Oncology fellow at Roswell Park Comprehensive Cancer Center in Buffalo, New York.

Dr. Medhavi Gupta, one of the participants in this past year's GRACE Patient Education Ambassador Program, shares a fantastic video series on Breast Cancer.

For this series, Dr. Gupta discusses Metastatic Triple-Negative Breast Cancer with Dr. Aditya Bardai.

Dr. Bardai is Assistant Professor of Medicine at Harvard Medical School and Attending Physician in Medical Oncology at Massachusetts General Hospital.

In this video, Drs. Gupta and Bardai discuss Antibody-Drug Conjugate Treatment Options

#breastcancer #Metastases #triplenegative #cancerGRACE #genentech #lilly

To join the conversation, visit https://cancergrace.org/forum.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Next Previous link

Previous Post Next Post

Article

The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.